These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study. Wang X, Song L, Yang J, Sun L, Moullaali TJ, Sandset EC, Delcourt C, Lindley RI, Robinson TG, Minhas JS, Arima H, Chalmers J, Kim JS, Sharma V, Wang JG, Pontes-Neto O, Lavados PM, Olavarría VV, Lee TH, Levi C, Martins SO, Thang NH, Anderson CS, on behalf of the ENCHANTED Investigators. Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956 [Abstract] [Full Text] [Related]
9. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Huang Y, Sharma VK, Robinson T, Lindley RI, Chen X, Kim JS, Lavados P, Olavarría V, Arima H, Fuentes S, Nguyen HT, Lee TH, Parsons MW, Levi C, Demchuk AM, Bath PM, Broderick JP, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Pandian J, Ricci S, Stapf C, Woodward M, Wang J, Chalmers J, Anderson CS, ENCHANTED investigators. Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995 [Abstract] [Full Text] [Related]
10. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial. Minhas JS, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Donnan GA, Kim JS, Lavados PM, Lee TH, Martins SCO, Olavarría VV, Pandian JD, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Thang NH, Wang JG, Woodward M, Chalmers J, Anderson CS, Robinson TG, ENCHANTED Investigators. Cerebrovasc Dis; 2018 Jul; 45(5-6):213-220. PubMed ID: 29705803 [Abstract] [Full Text] [Related]
11. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis. Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S. J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340 [Abstract] [Full Text] [Related]
12. Post-thrombolytic blood pressure and symptomatic intracerebral hemorrhage. Waltimo T, Haapaniemi E, Surakka IL, Melkas S, Sairanen T, Sibolt G, Tatlisumak T, Strbian D. Eur J Neurol; 2016 Dec; 23(12):1757-1762. PubMed ID: 27529662 [Abstract] [Full Text] [Related]
19. Relationship between Blood Pressure and Outcomes in Acute Ischemic Stroke Patients Administered Lytic Medication in the TIMS-China Study. Wu W, Huo X, Zhao X, Liao X, Wang C, Pan Y, Wang Y, Wang Y, TIMS-CHINA investigators. PLoS One; 2016 Mar; 11(2):e0144260. PubMed ID: 26828609 [Abstract] [Full Text] [Related]
20. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin. Mazya MV, Lees KR, Markus R, Roine RO, Seet RC, Wahlgren N, Ahmed N, Safe Implementation of Thrombolysis in Stroke Investigators. Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571 [Abstract] [Full Text] [Related] Page: [Next] [New Search]